MedTrace Logo

Soft Tissue Stability in the Esthetic Zone: A Randomized Clinical Trial Comparing Vestibular Socket Therapy With Contour Augmentation for Compromised Adjacent Sockets

NCT06673446 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-07-08

No results posted yet for this study

Summary

While early implant placement with guided bone regeneration (GBR) offers advantages, the desire for reduced treatment time and fewer surgical steps continues to drive the exploration of alternative approaches. In this context, the recent introduction of vestibular socket therapy (VST) presents an intriguing option. VST utilizes a minimally invasive tunnel access technique through the vestibular area to perform socket augmentation for immediate implant placement in compromised extraction sockets .

Conditions

  • Dental Implant in Compromised Adjacent Sockets

Interventions

PROCEDURE

vestibular socket therapy

atraumatic extraction to the hopeless teeth will be performed using periotomes followed by conventional forceps under local anesthesia. 1. Access and Socket Preparation: * A small incision (1 cm) is made on (vestibular area) near the base of the extracted teeth, extending slightly towards neighboring teeth. This creates a pouch for accessing the socket and surrounding bone. * Using special instruments from the VST kit, the gum tissue is carefully dissected to expose the underlying bone. 2. Immediate Implant Placement with Guide: \* A prefabricated surgical guide ensures precise positioning of the implants directly into the socket. 3. Bone Grafting and Membrane: * A mixture of bone chips harvested from the surgical site (autogenous bone) and a bone-grafting material (deproteinized bovine bone mineral) is used to fill any gaps and support the implant, especially in the labial bone wall (labial plate). * A special 0.6 mm thick membrane is inserted through the access incision. This membra

Sponsors & Collaborators

  • British University In Egypt

    lead OTHER

Principal Investigators

  • Mohamed Gamaleldin ahmed youssef, BDS · The British University in Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-25
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06673446 on ClinicalTrials.gov